Diacurimap 25 Mg 30 Tablets

Diacurimap 25 Mg 30 Tablets

Description:

Diacurimap 25 mg 30 tablets is a prescription oral antidiabetic medicine used to help control high blood sugar in adults with type 2 diabetes mellitus. It contains empagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor that works in the kidneys to increase glucose excretion in the urine, thereby lowering blood glucose levels. Diacurimap is used along with a proper diet, regular exercise, and, when needed, other antidiabetic medicines. It is also indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes who have established cardiovascular disease. This product is part of diabetes care and health prevention, and must be used under medical supervision.

Indications:

• Management of blood glucose levels in adults with type 2 diabetes mellitus as an adjunct to diet and exercise.
• Can be used alone (monotherapy) or in combination with other antidiabetic medicines such as metformin, insulin, or other oral agents, as prescribed by the doctor.
• Reduction of the risk of cardiovascular death in adults with type 2 diabetes and known cardiovascular disease.
• Helps improve glycemic control and may assist in long-term diabetes-related complication prevention when used as part of a comprehensive diabetes management plan.

Active Ingredients / Key Components:

• Empagliflozin – 25 mg per film-coated tablet.
• Other inactive ingredients (excipients) are present to form the film-coated tablet; detailed excipient list and their concentrations , please check the product leaflet or the manufacturer’s official website.

Dosage & Administration / How to Use:

• Usual adult dose: 25 mg (one tablet) once daily, or as directed by your physician. Some patients may start at a lower dose (such as 10 mg) depending on kidney function and overall treatment plan; follow your doctor’s instructions strictly.
• Route of administration: Oral use only.
• Take the tablet once daily, preferably at the same time each day, with or without food.
• Swallow the tablet whole with a glass of water. Do not crush, break, or chew the film-coated tablet unless your doctor or pharmacist advises otherwise.
• If you miss a dose, take it as soon as you remember on the same day. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take a double dose to make up for a missed dose.
• Your doctor may adjust the dose based on your kidney function, blood sugar control, and concomitant medications.
• Use this medicine as part of a complete diabetes management plan including diet, exercise, regular blood glucose monitoring, and periodic medical check-ups.

Clinical Benefits:

• Helps lower elevated blood sugar levels in adults with type 2 diabetes by promoting urinary glucose excretion.
• Contributes to reducing the risk of cardiovascular death in patients with type 2 diabetes and established cardiovascular disease.
• May support modest weight reduction and blood pressure improvement in some patients as a result of its mechanism of action (increased glucose and fluid loss), when used as prescribed.
• Can be combined with other antidiabetic medicines to achieve better glycemic control when monotherapy is insufficient.

Warnings & Contraindications:

• Contraindicated in patients with type 1 diabetes mellitus.
• Do not use in patients with diabetic ketoacidosis (DKA) or a history of DKA; this medicine is not suitable for treating or preventing DKA.
• Do not take Diacurimap if you have severe kidney problems, significantly reduced kidney function, or are on dialysis.
• Not recommended for children and adolescents under 18 years of age due to insufficient safety and efficacy data.
• Not recommended during pregnancy or breast-feeding. If you are pregnant, planning to become pregnant, or breastfeeding, consult your doctor immediately before using this medicine.
• Use with caution in elderly patients, those with low blood pressure, dehydration, or taking diuretics, as there is a risk of volume depletion and hypotension.
• May increase the risk of genital and urinary tract infections due to increased glucose in the urine; maintain good personal hygiene and report symptoms such as burning, pain, or unusual discharge.
• Inform your doctor if you have a history of recurrent urinary tract infections, genital infections, or problems with urination.
• Tell your doctor about all other medicines you are taking, especially insulin or insulin secretagogues (such as sulfonylureas), as the risk of hypoglycemia may increase and dose adjustments may be required.
• Stop the medicine and seek medical advice if you develop symptoms suggestive of ketoacidosis (nausea, vomiting, abdominal pain, excessive thirst, difficulty breathing, confusion, unusual fatigue) even if blood sugar is not very high.
• Consult your doctor before use if you have liver disease, cardiovascular disease, low blood pressure, or are on a low-salt diet.
• Consult your doctor before use if pregnant, nursing, taking medications, or have medical conditions such as kidney disease, liver disease, cardiovascular disease, or recurrent infections.
• Keep out of reach of children.

Side Effects:

• Common side effects may include increased urination, thirst, genital infections (such as yeast infections), and urinary tract infections.
• Other possible side effects include low blood pressure (especially in dehydrated patients or those on diuretics), dizziness, and mild increases in blood lipids or creatinine.
• Hypoglycemia (low blood sugar) can occur when empagliflozin is used in combination with insulin or insulin secretagogues; symptoms include sweating, tremor, hunger, palpitations, and confusion.
• Rare but serious side effects may include diabetic ketoacidosis (even with moderately elevated blood glucose), severe urinary tract infections, or Fournier’s gangrene (a rare but serious infection in the genital area). Seek immediate medical attention if you experience severe pain, swelling, fever, or unusual symptoms in the genital or perineal area.
• If you experience severe, persistent, or unusual side effects, stop taking the medicine and contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.

Specifications:

• Serving size: 1 tablet (25 mg empagliflozin).
• Count: 30 film-coated tablets per pack.
• Form: Film-coated tablet for oral use.
• Intended use: Prescription antidiabetic medicine for adults with type 2 diabetes mellitus.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.